New treatment for cancer approved for PBS listing
Pancreatic cancer drug Abraxane will be listed on the Pharmaceutical Benefits Scheme (PBS) from November 1. The Australian Government has committed over $92 million over four years to subsidise Abraxaneon the PBS. Pancreatic cancer is highly aggressive with very few…







